|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1001 G Street, NW |
Address2 | Suite 425W |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 9897-12
|
||||||||
|
6. House ID# 308370000
|
TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Michael Giuliani |
Date | 4/19/2024 9:18:03 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR2389/S1302 - Resident Physician Shortage Reduction Act
S2333 - Public Health Workforce Loan Repayment Act
Health Workforce Resilience Act
S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act
CLIA Waiver
PREVENT Pandemics Act
CURES 2.0
To prevent across-the-board direct spending cuts
Cytotechnologist labor rates
Remote digital telepathology
S 1000/HR 2377 SALSA
S 2140 - Patient Eligibility Restoration Act
HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs.
HR 1202/S 704 - REDI Act
HR 2761 - SPARC act
HR 2764/S1229 - Green New Deal for Health
HR 3248 - Diagnostic Lab Testing Transparency Act
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023
Student loan repayment for FPs
HR 4527 - HEALTH DATA Act
Primary Care and Health Workforce Expansion Act
S 1994 Counting Veterans Cancer Act
HR 4875 Doctors in our Borders Act
HR 2474 - Strengthening Medicare for Patients and Providers Act
Continuing Appropriations Act, 2024 and Other Extensions Act
Further Continuing Appropriations and Other Extensions Act, 2024
HR 6683
Gene Therapy
Precision Medicine Answers for Kids Today Act
S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021
Dr. Lorna Breen Health Care Provider Protection Act
PREVAIL
HR 6371 - budget neutrality bill
EDUCATE Act - Murphy DEI Bill
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Giuliani |
|
|
|
Darren |
Fenwick |
|
|
|
Michael |
Hurlbut |
|
|
|
Hannah |
Burriss |
|
|
|
Kristin |
McDonald |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues relating to surprise medical bills
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Advocating for relief from cuts to evaluation and management codes within Medicare
Issues relating to the debt limit
Issues relating to site-neutral payments
Issue relating to artificial intelligence
Issues relating to combatting fentanyl crisis
Issues relating to Medicare coverage pathways
Researching Long Covid
Fees paid on electronically submitting to insurers
Issues relating to the Clinical Laboratory Fee Schedule
Issues relating to forensic pathologist Loan repayment
funding for the CDC AMD program
Funding for lab test harmonization
Issues surrounding Health Data Privacy
Issues surrounding the Change Healthcare Cyber Attack
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Giuliani |
|
|
|
Darren |
Fenwick |
|
|
|
Michael |
Hurlbut |
|
|
|
Hannah |
Burriss |
|
|
|
Kristin |
McDonald |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |